Navigation Links
Pediatric clinical studies appear prone to bias, Hopkins review shows
Date:7/11/2010

keptical judgment about whether the conclusions fit the data, especially when a study boasts dramatic effects or drastic improvement.

Crocetti and colleagues used the Cochrane Collaboration tool, which assesses risk for bias along six critical aspects including randomization randomly assigning patients to different treatments and masking, the degree to which neither the patient nor the doctor knows which group of patients is receiving an active drug or intervention versus a placebo.

Investigators say that by analyzing each clinical trial along these and four other dimensions, the Cochrane Collaboration can answer what are perhaps the most important questions in medical research: How strong is the causal relationship between the therapy and the effect? and How valid are the conclusions made about the effect of the therapy?

Overall, 41 percent of the 146 trials in the review had improper or poorly described randomization techniques. Industry-funded trials were six times more likely to have high risk for biased randomization than government-funded trials or those funded by nonprofit organizations. And past research, the investigators point out, has shown that industry-funded trials are four to five times more likely to recommend an experimental drug.

"Industry funding is an important driver of medical discovery, but it is critical for investigators involved in such trials to ensure not only that the studies are conceived and executed cautiously with minimum risk for bias, but that any precautions taken against bias are also reported transparently," Crocetti says.

Trial registration and the transparency commitment it reflects is a key step in reducing bias or its influence, the researchers say. In their evaluation, registered trials were nearly 70 percent more likely to have robust randomization than non-registered trials, probably because the registration process itself forces researchers to answer many questions rel
'/>"/>

Contact: Ekaterina Pesheva
epeshev1@jhmi.edu
410-516-4996
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Molecular signatures may aid fight against pediatric liver disease
2. AAP Offers New Online Pediatric Symptom Checker on HealthyChildren.org
3. International child-health experts to converge on London for Excellence in Pediatrics
4. More Than Half of Pediatricians Make Diagnostic Errors: Survey
5. Pediatricians can help parents recognize overweight preschoolers
6. Sleep-disordered breathing is common but hard to detect in pediatric patients
7. Lemons to Aid Launches Pediatric Kit
8. New national study examines pediatric mobility aid-related injuries
9. Surgical procedure offers new option for pediatric patients with rare cancer in abdomen
10. ENT and Allergy Associates Welcomes Tamekia L. Wakefield, MD, Further Reinforcing its Pediatric Sinus Expertise and Capabilities in Queens
11. Renovations at Riley Hospital for Children will boost pediatric clinical research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... ... Paradise Valley Community College (PVCC) is proud to welcome nearly ... at Paradise Valley Community College. , PVCC Fine and Performing Arts Division|Ceramics Program is ... be on hand to meet the public and discuss their work, in a remarkable ...
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... With ... of a mouse all within Final Cut Pro X. With TransCel users have full ... the frame width, background color, speed method, frame color, inner color, text, and more. ...
(Date:9/4/2015)... GA (PRWEB) , ... September 04, 2015 , ... ... Bogart and the surrounding communities, is launching a charity effort to provide for ... Commonly referred to as an enlarged heart, restrictive cardiomyopathy often leads to diastolic ...
(Date:9/4/2015)... Forge, PA (PRWEB) , ... September 04, 2015 , ... ... growth in and around the home is quite common. Mold can grow anywhere - ... areas around leaking pipes. Checking for excessive moisture and water in the home is ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® ... medical devices, announced its only mission and research focus: Water Life Science®. In ... Kleyne, body water evaporation is becoming dangerously accelerated. As a result of the ...
Breaking Medicine News(10 mins):Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3
... Mentice, Inc. (a wholly owned,subsidiary of Mentice AB, ... training applications within the field of medicine,has recently ... Americas., Mr. Shannon brings to Mentice over ... within the areas of Healthcare and Life Science.,He ...
... Calif., March 26 Endocare, Inc.,(Nasdaq: ENDO ), ... minimally invasive technologies for tissue and tumor,ablation, today announced ... the B. Riley & Co. 9th Annual Las Vegas ... Friday, April 4, 2008. The conference is,being held at ...
... breast cancer in five out of every six positive scans ... women with a high, inherited risk of developing the disease. ... a major impact on a womans decision whether or not ... (Wednesday 26 March) in the April issue of the cancer ...
... NEW YORK, March 25 Diabetes is one of ... The American Diabetes,Association estimates that some 21 million Americans ... it. Today is the twentieth anniversary of,American Diabetes Alert ... they are at risk. For many people, diabetes can ...
... new study reviewing 75 group-randomized cancer trials over a ... studies used appropriate statistical methods to analyze the results. ... that interventions to prevent disease or reduce cancer risks ... been. , More than a third of the trials ...
... With Expanded Resources for Individuals With,Autism and ... 25 Danya,International, Inc. (Danya), a health ... acquired AutismOnline.org, a trusted,resource for individuals with ... parents and caregivers to support, research, and,products ...
Cached Medicine News:Health News:Mentice, Inc. Announces Appointment of Vice-President, Sales and Marketing, Americas 2Health News:Endocare to Present at the B. Riley & Co. 9th Annual Las Vegas Investor Conference 2Health News:MRI's high false positive rate has little impact on women's choice of preventive mastectomy 2Health News:MRI's high false positive rate has little impact on women's choice of preventive mastectomy 3Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 2Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 3Health News:AutismOnline.org Partners With Leading Health Communications Firm for Support 2
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
... flexibility to accommodate EIA microplate and IFA slide ... workloads, the unique modular design allows for efficient ... can be controlled by a single computer. Low ... EIA to IFA in less than 30 seconds. ...
... Clear Cornea Incision System - the first ... Cataract surgeon. The System has been methodically ... costly diamond knives. Beaver safety knives ... designed to both protects healthcare workers from ...
... Built on the market leading optical performance ... has been optimized for even better views ... system, including a new XHL Xenon Halogen ... cornea and clear, high resolution images of ...
The NIAGARA Thermal Retention System (TRS) maintains the temperature of prewarmed irrigation fluid continuously as it is delivered through the Corson®, Surgiflex® WAVE™, or Surgiflex D...
Medicine Products: